Last reviewed · How we verify
domestic compared vaccine
A vaccine that stimulates the immune system to recognize and respond to specific disease antigens.
At a glance
| Generic name | domestic compared vaccine |
|---|---|
| Sponsor | Beijing Center for Disease Control and Prevention |
| Drug class | vaccine |
| Modality | Biologic |
| Therapeutic area | Immunology |
| Phase | FDA-approved |
Mechanism of action
Vaccines work by introducing a harmless form of a pathogen (or its components) to train the immune system to produce antibodies and cellular immunity against that pathogen. This allows the body to mount a rapid and effective immune response upon future exposure to the actual disease agent.
Approved indications
Common side effects
- Injection site reactions (pain, redness, swelling)
- Fever
- Fatigue
- Myalgia
Key clinical trials
- Immunogenicity of RSV Vaccines in Residents of Long-Term Care Facilities (LTCF) (PHASE4)
- Immunogenicity and Safety Following In-House Recombinant Hepatitis B Vaccine in Indonesian Population (Phase III) (PHASE3)
- HPV Vaccine, Imiquimod, and Metformin Combination Trial (PHASE2)
- Vitamin D Supplementation And Varicella Zoster Virus Vaccine Responsiveness In Older Long-Term Care Residents (PHASE1)
- Immunogenicity of Influenza Vaccine in Long Term Care (NA)
- LT Vaccine Patch Self-Administration Study (PHASE2)
- Safety and Immunogenicity Study of Split Influenza Virus Vaccine in Different Age Groups (PHASE4)
- Sublingual Immunotherapy in Children With Allergic Rhinitis (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: